COVID-19 Antivirals: Part Two

COVID-19 Antivirals: Part Two

Last week, we began our two-part series on COVID-19 antiviral drugs by reviewing the stages of the Sars-Cov-2 (the virus that causes COVID-19) lifecycle that might be prone to attack by these drugs, and explained how hydroxychloroquine (HCQ) works and discussed the...
Unmasking Multiple Sclerosis

Unmasking Multiple Sclerosis

Multiple SCLEROSIS Awareness March is Multiple Sclerosis (MS) Awareness Month, so this WEEKLY takes a look at the science behind the disease and some of the treatments developed for it. MS typically occurs in susceptible individuals between the ages of 20 and 50, and...
Hope On The Horizon For Huntington’s

Hope On The Horizon For Huntington’s

Hope on the horizon for HUNTINGTON’S No question about it, Huntington’s disease (HD) is cruel. In the beginning, sufferers of this fatal neurodegenerative disorder experience involuntary movement and mood disturbance, most often in the form of depression. As the...
COVID-19 Antivirals

COVID-19 Antivirals

For the past several weeks, we’ve been focusing on explaining the science behind vaccines, explaining the different types of vaccines that are in development to prevent Covid-19, the disease caused by the novel coronavirus Sars-Cov-2. This week, guest author Kevin...
DNA Vaccines Explained

DNA Vaccines Explained

Last week, we overviewed vaccine development and manufacture, focusing on those that use whole pathogens to protect us from a disease. This week, we examine subunit, polysaccharide, and DNA/RNA-based vaccines, which use different strategies to fight infection. We also...
Vaccines: Powerful Simplicity

Vaccines: Powerful Simplicity

As the COVID-19 pandemic continues to spread, governments, citizens, and healthcare workers everywhere turn their hopes to a new vaccine that will stop transmission. This WEEKLY takes a look at different types of vaccines and their manufacture, as well as what kind of...